Clostridium Difficile (C. diff) Clinical Research (ECOSPOR III)

Is another Clostridium difficile infection getting in the way of your life?

Consider this medical research study of an investigational medication that may help prevent these infections from recurring.

When you or someone you care about has a Clostridium difficile infection (CDI), the effects can be difficult to handle. Every day, a person can experience diarrhea that is frequent, out of control, and worst of all, can begin without any warning.

For adults who live with recurrent CDI, doctors and researchers are conducting the ECOSPOR Ill medical research study. In this study, investigators want to evaluate the safety and effectiveness of an investigational medication to see if it helps prevent recurring episodes of CD.

To qualify for this study, a person must:

- Be 18 years of age or older

- Have a documented history of at least 3 episodes of CDI in the last 12 months, including the current episode

All study-related visits, tests, and medication will be provided to participants at no cost. Reimbursement for time and travel may be provided.

To learn more, visit: www.serescdiffstudy.com

Contact ACR at 801-542-8198.